Prosecution Insights
Last updated: October 02, 2026

Examiner: GABR, MOHAMED GAMIL

Tech Center 3700 • Art Units: 3731 3734 3771 3795

This examiner grants 80% of resolved cases

Analysis

Mohamed Gamil Gabr serves in Tech Center 3700 and Art Unit 3731. He has overseen 539 resolved cases, resulting in an allowance rate of 80.5 percent. This 80.5 percent allowance rate provides a baseline for applicants evaluating their chances of success during the examination process. The data indicates that applications assigned to his docket have a high probability of reaching a grant.

Direct communication appears to be a beneficial strategy with this examiner. Gabr's data shows an interview lift of 21.9 percent, indicating that cases involving an interview have a higher probability of allowance compared to those without such interaction. This 21.9 percent lift suggests that practitioners can effectively use interviews to address examiner concerns and advance prosecution.

The median time to allowance for Gabr is 1044 days. This 1044 day period represents the typical duration from initial filing to the grant of a patent. With 539 resolved cases, this median provides a reliable estimate for pendency expectations. Applicants should factor this timeframe into their long-term strategy when working within Art Unit 3731.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

80.5%
Allow Rate
+10.5% vs TC avg
569
Total Applications
+21.9%
Interview Lift
1044
Avg Prosecution Days
Based on 539 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
27.5%
§102 Novelty
43.4%
§103 Obviousness
20.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18946662 DRIVE ROD AND KNIFE BLADE FOR AN ARTICULATING SURGICAL INSTRUMENT Final Rejection Covidien LP
19065709 HEMOSTASIS CLIP WITH COLLAPSIBLE CAPSULE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18934492 EXTRAVASCULAR SECURING ELEMENT FOR PERCUTANEOUS DEVICE ENABLED LEFT ATRIAL APPENDAGE OCCLUSION Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18652935 ASPIRATION CATHETER WITH AUTOMATIC SENSING Non-Final OA Boston Scientific Scimed, Inc.
17858655 DEVICES, SYSTEMS AND METHODS FOR TISSUE RESECTION Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18941825 REUSABLE SURGICAL INSTRUMENT WITH SINGLE-USE TIP AND INTEGRATED TIP COVER Non-Final OA Intuitive Surgical Operations, Inc.
18942285 COMMISSURE COVER FOR PROSTHETIC VALVE Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18896523 STEERABLE CATHETER WITH MULTIPLE PULL WIRES Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18812877 EXPANDABLE SHEATH WITH SEGMENTED INNER MEMBER Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18866770 DELIVERY AND RETRIEVAL SYSTEM FOR A MEDICAL DEVICE Non-Final OA Medtronic, Inc.
19073516 Injectable Soft Anchors and Methods of Tissue Repairs Non-Final OA Arthrex, Inc.
18807529 CATHETER BALLOON Final Rejection TERUMO KABUSHIKI KAISHA
18785138 FILAMENTARY DEVICES FOR TREATMENT OF VASCULAR DEFECTS Non-Final OA MICROVENTION, INC.
19012793 CATHETER-BASED SYSTEM FOR DELIVERY AND RETRIEVAL OF A LEADLESS PACEMAKER Non-Final OA PACESETTER, INC.
19096165 TORQUEABLE DEVICES AND METHODS FOR REMOVING AN EMBOLUS Non-Final OA INNOVA VASCULAR, INC.
18922685 METHOD AND APPARATUS FOR PROVIDING INCREASED VISUALIZATION AND MANIPULATION OF A BODY SIDE WALL Non-Final OA Cornell University
18594203 GUIDE RAIL ACTUATION ASSEMBLY FOR BALLOON DILATION INSTRUMENT Final Rejection Acclarent, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month